🦊/Lists

Biotech Investors & VC Firms in Europe

832 firms in this list, with a median first check of $500K. 187 of them lead rounds. Generated from verified public data and updated continuously.

Procuritas
StockholmGrowth
32 people
LSP (Life Sciences Partners)
AmsterdamSeries A–Late Stage$10.8M – $64.8M
41 people
Air Street Capital
St. Peter PortPre-Seed–Growth$500K – $10M
23 people
IQ Capital
LondonPre-Seed–Growth$1M – $40M
20 people
Kreos Capital
LondonSeries A–Late Stage
43 people
Jeito Capital
Paris
39 people
Backed
LondonPre-Seed–Series A$500K – $5M
15 people
BlueYard Capital
BerlinPre-Seed–Series A$500K – $5M
18 people
Verve Ventures
ZugSeed–Series B$1.1M – $2.2M
9 people
Kickfund
BaselPre-Seed–Series A$950K
9 people
SHS Capital
TübingenGrowth–Late Stage$10M – $50M
44 people
Novartis Venture Fund
BaselPre-Seed–Late Stage$5M – $25M
24 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Late Stage
34 people
Kindred Capital
LondonPre-Seed–Series A
22 people
HealthCap
StockholmSeed–Growth
34 people
Clarendon Fund Managers Ltd.
BelfastPre-Seed–Growth$25K – $3.9M
13 people
META Group
BrusselsSeed–Series A
42 people
KAYA
PraguePre-Seed–Late Stage$108K – $3.2M
15 people
Parkwalk Advisors
LondonSeed–Growth
30 people
Unruly Capital
LondonPre-Seed–Series A
3 people
Extantia Capital
BerlinPre-Seed–Series A$1.1M – $5.5M
25 people
Ysios Capital
BarcelonaSeries A–Late Stage$5.4M – $21.6M
25 people
Calculus Capital Ltd.
LondonSeed–Late Stage$2.5M
31 people
PSV
Kongens LyngbyPre-Seed–Series A$75.6K – $864K
32 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.